• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植排斥反应监测中经皮心内膜心肌活检的组织病理学特征:单中心经验

Histopathological Characteristics of Percutaneous Endomyocardial Biopsy in Heart Transplant Rejection Surveillance: A Single Center Experience.

作者信息

Farcas Anca Otilia, Stoica Mihai Ciprian, Voidazan Septimiu, Maier Ioana Maria, Maier Adrian Cornel, Suciu Horatiu, Sin Anca Ileana

机构信息

Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, Romania.

Department of Cell Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania.

出版信息

Biomedicines. 2024 Oct 4;12(10):2258. doi: 10.3390/biomedicines12102258.

DOI:10.3390/biomedicines12102258
PMID:39457571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505139/
Abstract

BACKGROUND

Heart transplantation (HT) remains the ultimate treatment for end-stage heart failure. An endomyocardial biopsy (EMB) is "the gold standard" diagnostic procedure used in HT rejection surveillance. The aim of this study is to provide a detailed analysis of the histopathological characteristics of the EMB and to investigate if there is a correlation between some histopathological changes, such as fibrosis, vasculitis, Quilty effect (Q.E.), myocytes damage, and the presence of episodes of acute rejection.

METHODS

In this retrospective study, 200 EMBs were included, coming from 65 patients transplanted in the Emergency Institute for Cardiovascular Diseases and Transplantation (ICvDT) Targu Mures between 2012 and 2024. Fibrosis, vasculitis, Q.E., myocyte damage, etc., were microscopically evaluated to see if these parameters correlate with rejection episodes.

RESULTS

The mean age was 38.18 years (SD 15.67), 25% of biopsies being recorded in the 41-50 age group. 77.14% of total acute cellular rejection (ACR) was of mild rejection, with most registered in the 11-20 age group; the cases of severe rejection being recorded in the 41-50 age group. Antibody-mediated rejection (AMR) was recorded more frequently in women with a representation of 23.4%, compared to 8.5% of men. 86.7% (39 cases) of the total number of EMBs with fibrosis score 3 and 71.4% (15 cases) of the total EMBs with fibrosis score 2 were recorded in men, compared to the 28.6% (6 cases) of fibrosis score 2 recorded in women ( = 0.013). 50.0% of all the EMB recorded in the 61-70 age group showed fibrosis score 3, compared to 34.8% of those from the 21-30 age group. The Q.E. was identified in 13% of the biopsies and, in some patients, it was observed across 3-4 successive biopsies. Mild vasculitis was associated in 34.9% of cases with ISHLT ≥ 1R and moderate vasculitis was associated in 87.5% of cases with ISHLT ≥ 1R.

CONCLUSIONS

Fibrosis was detected much more frequently in men and in the 61-70 age group. In addition to the histopathological changes specific to acute rejection, there are other pathological changes, such as the Q.E., and vasculitis and myocytes damage and disarray, that seem to suggest a close connection with rejection, but extensive studies are needed to confirm this.

摘要

背景

心脏移植(HT)仍然是终末期心力衰竭的最终治疗方法。心内膜心肌活检(EMB)是用于心脏移植排斥反应监测的“金标准”诊断程序。本研究的目的是对EMB的组织病理学特征进行详细分析,并调查某些组织病理学变化,如纤维化、血管炎、奎尔蒂效应(Q.E.)、心肌细胞损伤与急性排斥反应发作之间是否存在相关性。

方法

在这项回顾性研究中,纳入了200份EMB,这些样本来自2012年至2024年在特尔古穆列什心血管疾病与移植急诊研究所(ICvDT)接受移植的65名患者。对纤维化、血管炎、Q.E.、心肌细胞损伤等进行显微镜评估,以查看这些参数是否与排斥反应发作相关。

结果

平均年龄为38.18岁(标准差15.67),25%的活检记录在41 - 50岁年龄组。急性细胞排斥反应(ACR)总数的77.14%为轻度排斥反应,大多记录在11 - 20岁年龄组;重度排斥反应病例记录在41 - 50岁年龄组。抗体介导的排斥反应(AMR)在女性中记录更为频繁,占比23.4%,而男性为8.5%。纤维化评分为3的EMB总数中,86.7%(39例)为男性,纤维化评分为2的EMB总数中,71.4%(15例)为男性,而女性中纤维化评分为2的占28.6%(6例)(P = 0.013)。61 - 70岁年龄组记录的所有EMB中,50.0%显示纤维化评分为3,而21 - 30岁年龄组为34.8%。在13%的活检中发现了Q.E.,在一些患者中,在连续3 - 4次活检中均观察到。34.9%的病例中轻度血管炎与国际心脏和肺移植学会(ISHLT)≥1R相关,87.5%的病例中中度血管炎与ISHLT≥1R相关。

结论

在男性和61 - 70岁年龄组中纤维化的检测更为频繁。除了急性排斥反应特有的组织病理学变化外,还有其他病理变化,如Q.E.、血管炎以及心肌细胞损伤和紊乱,这些似乎表明与排斥反应有密切联系,但需要广泛研究来证实这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/6191ffcd9cbf/biomedicines-12-02258-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/0526298986c9/biomedicines-12-02258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/835ac431f2a8/biomedicines-12-02258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/be1ae1083f25/biomedicines-12-02258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/225399b3f3ff/biomedicines-12-02258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/6191ffcd9cbf/biomedicines-12-02258-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/0526298986c9/biomedicines-12-02258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/835ac431f2a8/biomedicines-12-02258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/be1ae1083f25/biomedicines-12-02258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/225399b3f3ff/biomedicines-12-02258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1202/11505139/6191ffcd9cbf/biomedicines-12-02258-g005.jpg

相似文献

1
Histopathological Characteristics of Percutaneous Endomyocardial Biopsy in Heart Transplant Rejection Surveillance: A Single Center Experience.心脏移植排斥反应监测中经皮心内膜心肌活检的组织病理学特征:单中心经验
Biomedicines. 2024 Oct 4;12(10):2258. doi: 10.3390/biomedicines12102258.
2
Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.根据国际心肺移植学会(ISHLT)2013年报告病理性抗体介导排斥反应(pAMR)的新分类对C4d阳性心内膜心肌活检(EMB)进行重新分类:来自波兰单中心研究的初步数据。
Ann Transplant. 2015 Jun 23;20:351-6. doi: 10.12659/AOT.893635.
3
Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?心脏移植术后患者心内膜心肌活检中奎尔蒂效应的患病率——从细胞性排斥反应到抗体介导的排斥反应?
Pol J Pathol. 2016;67(3):216-220. doi: 10.5114/pjp.2016.63772.
4
[Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].心脏移植病理学。(对167例移植心脏的1246份心内膜心肌活检的形态学研究)。早期、中期和晚期死亡原因
Pathologica. 1999 Apr;91(2):89-100.
5
Comparative histopathology of endomyocardial biopsies in chagasic and non-chagasic heart transplant recipients.恰加斯病心脏移植受者与非恰加斯病心脏移植受者心内膜心肌活检的比较组织病理学
J Heart Lung Transplant. 2001 May;20(5):534-43. doi: 10.1016/s1053-2498(00)00320-x.
6
Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).小儿心脏移植受者的心内膜心肌活检:一项有益的检查?(对1169例活检的分析)
Pediatr Transplant. 2000 Aug;4(3):186-92. doi: 10.1034/j.1399-3046.2000.00100.x.
7
Endomyocardial Biopsy and Prevalence of Acute Cellular Rejection in Heart Transplantation.心肌内膜活检与心脏移植中急性细胞排斥的流行情况。
Transplant Proc. 2021 Jan-Feb;53(1):318-323. doi: 10.1016/j.transproceed.2020.08.014. Epub 2020 Oct 8.
8
Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling.心脏移植排斥反应:从心内膜心肌活检到基因表达谱分析
Biomedicines. 2024 Aug 22;12(8):1926. doi: 10.3390/biomedicines12081926.
9
Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.心内膜心肌活检中淋巴细胞亚群浸润与供体特异性抗体及急性抗体介导排斥反应的相关性
Cardiovasc Pathol. 2015 May-Jun;24(3):168-72. doi: 10.1016/j.carpath.2014.11.001. Epub 2014 Nov 7.
10
Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.心脏移植排斥反应中心肌损伤的负担:心肌损伤的闪烁显像证据以及心肌细胞坏死和凋亡的组织学证据。
J Nucl Cardiol. 2000 Mar-Apr;7(2):132-9. doi: 10.1016/s1071-3581(00)90033-3.

本文引用的文献

1
Endomyocardial biopsy through the left internal jugular vein in heart transplant recipients: a single center experience.经左颈内静脉行心内膜心肌活检在心脏移植受者中的应用:单中心经验。
J Cardiovasc Med (Hagerstown). 2024 Sep 1;25(9):700-703. doi: 10.2459/JCM.0000000000001655. Epub 2024 Aug 2.
2
Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.心脏移植后采用双重非侵入性检测进行急性细胞排斥反应监测:来自 Surveillance HeartCare Outcomes 注册研究的结果。
J Heart Lung Transplant. 2024 Sep;43(9):1409-1421. doi: 10.1016/j.healun.2024.05.003. Epub 2024 May 15.
3
Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era.
当代心脏移植患者急性排斥反应发生率与心内膜心肌活检并发症的比较
Transplantation. 2024 May 1;108(5):1220-1227. doi: 10.1097/TP.0000000000004882. Epub 2023 Dec 15.
4
Heart Transplantation: Indications, Surgical Techniques, and Complications.心脏移植:适应证、手术技术及并发症。
Radiol Clin North Am. 2023 Sep;61(5):847-859. doi: 10.1016/j.rcl.2023.04.011. Epub 2023 May 15.
5
Increased fibrosis and microvessel disease in allograft endomyocardial biopsies of children with chronic graft failure due to cardiac allograft vasculopathy.在因心脏移植血管病变导致慢性移植失败的儿童同种异体心肌内膜活检中,纤维化和微血管疾病增加。
Cardiovasc Pathol. 2023 Mar-Apr;63:107509. doi: 10.1016/j.carpath.2022.107509. Epub 2022 Nov 25.
6
Ischemic Versus Nonischemic Recipient Indication Does Not Impact Outcome After Heart Transplantation.缺血与非缺血受体适应证对心脏移植后结果无影响。
Exp Clin Transplant. 2022 Jun;20(6):580-584. doi: 10.6002/ect.2022.0091.
7
Noninvasive biomarkers in heart transplant: 2020-2021 year in review.心脏移植中的非侵入性生物标志物:2020-2021 年回顾。
Curr Opin Organ Transplant. 2022 Feb 1;27(1):7-14. doi: 10.1097/MOT.0000000000000945.
8
Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection.人类心肌线粒体氧化能力在轻度急性心脏移植排斥反应中受损。
ESC Heart Fail. 2021 Dec;8(6):4674-4684. doi: 10.1002/ehf2.13607. Epub 2021 Sep 6.
9
Cardiac Fibrosis and Fibroblasts.心脏纤维化与成纤维细胞
Cells. 2021 Jul 6;10(7):1716. doi: 10.3390/cells10071716.
10
Trends in post-heart transplant biopsies for graft rejection versus nonrejection.心脏移植术后活检中关于移植物排斥与非排斥情况的趋势。
Proc (Bayl Univ Med Cent). 2021 Jan 26;34(3):345-348. doi: 10.1080/08998280.2021.1873032.